Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
3.630
+0.090 (2.54%)
Mar 31, 2025, 2:21 PM EDT - Market open

Company Description

Sera Prognostics, Inc., a women’s health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States.

The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman for the prediction of the expectant mother’s risk of delivering spontaneously.

It is also developing a pipeline of novel blood-based biomarker tests for major pregnancy-related conditions, including time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction.

The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Sera Prognostics, Inc.
Sera Prognostics logo
Country United States
Founded 2008
IPO Date Jul 15, 2021
Industry Medical Devices
Sector Healthcare
Employees 64
CEO Evguenia Lindgardt

Contact Details

Address:
2749 East Parleys Way, Suite 200
Salt Lake City, Utah 84109
United States
Phone 801 990 0520
Website sera.com

Stock Details

Ticker Symbol SERA
Exchange NASDAQ
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
IPO Price $16.00
CIK Code 0001534969
CUSIP Number 81749D107
ISIN Number US81749D1072
Employer ID 26-1911522
SIC Code 8071

Key Executives

Name Position
Evguenia Lindgardt M.B.A. President, Chief Executive Officer and Director
Austin Aerts Chief Financial Officer
Dr. John J. Boniface Ph.D. Chief Scientific Officer
Dr. Gregory C. Critchfield M.D., M.S. Executive Director
Robert G. Harrison Chief Information Officer
Benjamin G. Jackson J.D. General Counsel
Dr. Paul Kearney Ph.D. Chief Data Officer

Latest SEC Filings

Date Type Title
Mar 19, 2025 S-8 Securities to be offered to employees in employee benefit plans
Mar 19, 2025 10-K Annual Report
Mar 19, 2025 8-K Current Report
Mar 10, 2025 144 Filing
Mar 10, 2025 144 Filing
Mar 7, 2025 144 Filing
Mar 7, 2025 144 Filing
Mar 7, 2025 144 Filing
Mar 7, 2025 144 Filing
Mar 7, 2025 144 Filing